{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T17:41:43Z","timestamp":1771263703320,"version":"3.50.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China (CN)","doi-asserted-by":"publisher","award":["30972581"],"award-info":[{"award-number":["30972581"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China (CN)","doi-asserted-by":"publisher","award":["8120316"],"award-info":[{"award-number":["8120316"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province (CN)","doi-asserted-by":"publisher","award":["BK2012544"],"award-info":[{"award-number":["BK2012544"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20151120"],"award-info":[{"award-number":["BK20151120"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Laboratory Research of Parasitic Disease Prevention and Control Platform","award":["wk014-002"],"award-info":[{"award-number":["wk014-002"]}]},{"DOI":"10.13039\/501100008868","name":"Jiangsu Science and Technology Department","doi-asserted-by":"crossref","award":["BM2015024"],"award-info":[{"award-number":["BM2015024"]}],"id":[{"id":"10.13039\/501100008868","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasites Vectors"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s13071-016-1301-3","type":"journal-article","created":{"date-parts":[[2016,1,20]],"date-time":"2016-01-20T15:43:59Z","timestamp":1453304639000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Oxadiazole-2-oxides may have other functional targets, in addition to SjTGR, through which they cause mortality in Schistosoma japonicum"],"prefix":"10.1186","volume":"9","author":[{"given":"Li-Jun","family":"Song","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Hua","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gu-Ping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu-Ren","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuang","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Long","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bainian","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuan-Xin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,1,20]]},"reference":[{"key":"1301_CR1","first-page":"CD000528","volume":"2","author":"A Danso-Appiah","year":"2013","unstructured":"Danso-Appiah A, Olliaro PL, Donegan S, Sinclair D, Utzinger J. Drugs for treating Schistosoma mansoni infection. Cochrane Database Syst Rev. 2013;2:CD000528.","journal-title":"Cochrane Database Syst Rev."},{"key":"1301_CR2","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/S0140-6736(06)69440-3","volume":"368","author":"B Gryseels","year":"2006","unstructured":"Gryseels B, Polman K, Clerinx J, Kestens L. Human schistosomiasis. Lancet. 2006;368:1106\u201318.","journal-title":"Lancet."},{"key":"1301_CR3","first-page":"621","volume":"24","author":"H Zheng","year":"2012","unstructured":"Zheng H, Zhang LJ, Zhu R, Xu J, Li SZ, Guo JG, et al. Schistosomiasis situation in People\u2019s Republic of China in 2011. Chin J Schisto Control. 2012;24:621\u20136.","journal-title":"Chin J Schisto Control"},{"key":"1301_CR4","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1007\/s00436-012-3151-z","volume":"111","author":"W Wang","year":"2012","unstructured":"Wang W, Wang L, Liang YS. Susceptibility or resistance of praziquantel in human schistosomiasis: a review. Parasitol Res. 2012;111:1871\u20135.","journal-title":"Parasitol Res."},{"key":"1301_CR5","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1002\/cmdc.201000202","volume":"5","author":"A Domling","year":"2010","unstructured":"Domling A, Khoury K. Praziquantel and schistosomiasis. Chemmedchem. 2010;5:1420\u201334.","journal-title":"Chemmedchem."},{"key":"1301_CR6","doi-asserted-by":"crossref","first-page":"8790","DOI":"10.1021\/jm301077m","volume":"55","author":"M Patra","year":"2012","unstructured":"Patra M, Ingram K, Pierroz V, Ferrari S, Spingler B, Keiser J, et al. Ferrocenyl derivatives of the anthelmintic praziquantel: design, synthesis, and biological evaluation. J Med Chem. 2012;55:8790\u20138.","journal-title":"J Med Chem."},{"key":"1301_CR7","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1016\/j.bmcl.2010.03.001","volume":"20","author":"YX Dong","year":"2010","unstructured":"Dong YX, Chollet J, Vargas M, Mansour NR, Bickle Q, Alnouti Y, et al. Praziquantel analogs with activity against juvenile Schistosoma mansoni. Bioorg Med Chem Lett. 2010;20:2481\u20134.","journal-title":"Bioorg Med Chem Lett."},{"key":"1301_CR8","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1002\/chem.201204291","volume":"19","author":"M Patra","year":"2013","unstructured":"Patra M, Ingram K, Pierroz V, Ferrari S, Spingler B, Gasser RB, et al. (\u03b7(6)-Praziquantel)Cr(CO)3] derivatives with remarkable in vitro anti-schistosomal activity. Chemistry. 2013;19:2232\u20135.","journal-title":"Chemistry"},{"key":"1301_CR9","doi-asserted-by":"crossref","first-page":"4154","DOI":"10.1016\/j.bmcl.2007.05.063","volume":"17","author":"F Ronketti","year":"2007","unstructured":"Ronketti F, Ramana AV, Chao-Ming X, Pica-Mattoccia L, Cioli D, Todd MH. Praziquantel derivatives I: Modification of the aromatic ring. Bioorg Med Chem Lett. 2007;17:4154\u20137.","journal-title":"Bioorg Med Chem Lett."},{"key":"1301_CR10","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/j.bmcl.2011.12.133","volume":"22","author":"WW Duan","year":"2012","unstructured":"Duan WW, Qiu SJ, Zhao Y, Sun H, Qiao C, Xia CM. Praziquantel derivatives exhibit activity against both juvenile and adult Schistosoma japonicum. Bioorg Med Chem Lett. 2012;22:1587\u201390.","journal-title":"Bioorg Med Chem Lett."},{"key":"1301_CR11","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/cbdd.12153","volume":"82","author":"ZX Wang","year":"2013","unstructured":"Wang ZX, Chen JL, Qiao C. Praziquantel derivatives with antischistosomal activity: aromatic ring modification. Chem Biol Drug Des. 2013;82:216\u201325.","journal-title":"Chem Biol Drug Des."},{"key":"1301_CR12","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.bmcl.2011.11.108","volume":"22","author":"PS Sadhu","year":"2012","unstructured":"Sadhu PS, Kumar SN, Chandrasekharam M, Pica-Mattoccia L, Cioli D, Rao VJ. Synthesis of new praziquantel derivatives: potential candidates for the treatment of schistosomiasis. Bioorg Med Chem Lett. 2012;22:1103\u20136.","journal-title":"Bioorg Med Chem Lett."},{"key":"1301_CR13","doi-asserted-by":"crossref","first-page":"3395","DOI":"10.3390\/ijms14023395","volume":"14","author":"D Ndjonka","year":"2013","unstructured":"Ndjonka D, Rapado LN, Silber AM, Liebau E, Wrenger C. Natural products as a source for treating neglected parasitic diseases. Int J Mol Sci. 2013;14:3395\u2013439.","journal-title":"Int J Mol Sci."},{"key":"1301_CR14","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/1756-3305-6-162","volume":"6","author":"J Liu","year":"2013","unstructured":"Liu J, Dyer DH, Cheng J, Wang J, Wang S, Yang Z, et al. Aldose reductase from Schistosoma japonicum: crystallization and structure-based inhibitor screening for discovering antischistosomal lead compounds. Parasit Vectors. 2013;6:162.","journal-title":"Parasit Vectors."},{"key":"1301_CR15","doi-asserted-by":"crossref","first-page":"6474","DOI":"10.1021\/jm901021k","volume":"52","author":"G Rai","year":"2009","unstructured":"Rai G, Sayed AA, Lea WA, Luecke HF, Chakrapani H, Prast-Nielsen S, et al. Structure mechanism insights and the role of nitric oxide donation guide the development of oxadiazole-2-oxides as therapeutic agents against schistosomiasis. J Med Chem. 2009;52:6474\u201383.","journal-title":"J Med Chem."},{"key":"1301_CR16","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nm1737","volume":"14","author":"AA Sayed","year":"2008","unstructured":"Sayed AA, Simeonov A, Thomas CJ, Inglese J, Austin CP, Williams DL. Identification of oxadiazoles as new drug leads for the control of schistosomiasis. Nat Med. 2008;14:407\u201312.","journal-title":"Nat Med."},{"key":"1301_CR17","doi-asserted-by":"crossref","first-page":"e64984","DOI":"10.1371\/journal.pone.0064984","volume":"8","author":"J Liu","year":"2013","unstructured":"Liu J, Dyer D, Wang J, Wang S, Du X, Xu B, et al. 3-oxoacyl-ACP reductase from Schistosoma japonicum: integrated in silico-in vitro strategy for discovering antischistosomal lead compounds. Plos One. 2013;8:e64984.","journal-title":"Plos One."},{"key":"1301_CR18","doi-asserted-by":"crossref","first-page":"e31456","DOI":"10.1371\/journal.pone.0031456","volume":"7","author":"LJ Song","year":"2012","unstructured":"Song LJ, Li JH, Xie SY, Qian CY, Wang J, Zhang W, et al. Thioredoxin Glutathione Reductase as a Novel Drug Target: Evidence from Schistosoma japonicum. Plos One. 2012;7:e31456.","journal-title":"Plos One."},{"key":"1301_CR19","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1017\/S0031182000079245","volume":"107","author":"R Harrop","year":"1993","unstructured":"Harrop R, Wilson RA. Protein synthesis and release by cultured schistosomula of Schistosoma mansoni. Parasitology. 1993;107:265\u201374.","journal-title":"Parasitology."},{"key":"1301_CR20","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1017\/S0031182009991739","volume":"137","author":"J Keiser","year":"2010","unstructured":"Keiser J. In vitro and in vivo trematode models for chemotherapeutic studies. Parasitology. 2010;137:589\u2013603.","journal-title":"Parasitology."},{"key":"1301_CR21","doi-asserted-by":"crossref","first-page":"419","DOI":"10.2307\/3273678","volume":"33","author":"TK Yolles","year":"1947","unstructured":"Yolles TK, Moore DV, De Giusti DL, Ripsom CA, Meleney HE. A technique for the perfusion of laboratory animals for the recovery of schistosomes. J Parasitol. 1947;33:419\u201326.","journal-title":"J Parasitol."},{"key":"1301_CR22","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s00436-009-1674-8","volume":"106","author":"LG Magalh\u00e3es","year":"2010","unstructured":"Magalh\u00e3es LG, Kapadia GJ, da Silva Tonuci LR, Ixeta SC, Parreira NA, et al. In vitro schistosomicidal effects of some phloroglucinol derivatives from Dryopteris species against Schistosoma mansoni adult worms. Parasitol Res. 2010;106:395\u2013401.","journal-title":"Parasitol Res"},{"key":"1301_CR23","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1017\/S0031182009990965","volume":"137","author":"T Manneck","year":"2010","unstructured":"Manneck T, Haggenm\u00fcller Y, Keiser J. Morphological effects and tegumental alterations induced by mefloquine on schistosomula and adult flukes of Schistosoma mansoni. Parasitology. 2010;137:85\u201398.","journal-title":"Parasitology."},{"key":"1301_CR24","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s00436-009-1656-x","volume":"106","author":"SH Xiao","year":"2009","unstructured":"Xiao SH, Mei JY, Jiao PY. The in vitro effect of mefloquine and praziquantel against juvenile and adult Schistosoma japonicum. Parasitol Res. 2009;106:237\u201346.","journal-title":"Parasitol Res."},{"key":"1301_CR25","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/QCO.0b013e328349156f","volume":"24","author":"CR Caffrey","year":"2011","unstructured":"Caffrey CR, Secor WE. Schistosomiasis: From drug deployment to drug development. Curr Opin Infect Dis. 2011;24:410\u20137.","journal-title":"Curr Opin Infect Dis."},{"key":"1301_CR26","doi-asserted-by":"crossref","first-page":"167","DOI":"10.4269\/ajtmh.1995.53.167","volume":"53","author":"FF Stelma","year":"1995","unstructured":"Stelma FF, Talla I, Sow S, Kongs A, Niang M, Polman K, et al. Efficacy and side effects of praziquantel in an epidemic focus of Schistosoma mansoni. Am J Trop Med Hyg. 1995;53:167\u201370.","journal-title":"Am J Trop Med Hyg."},{"key":"1301_CR27","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1351\/pac200476050973","volume":"76","author":"A Gasco","year":"2004","unstructured":"Gasco A, Fruttero R, Sorba G, Di Stilo A, Calvino R. NO donors: Focus on furoxan derivatives. Pure Appl Chem. 2004;76:973\u201381.","journal-title":"Pure Appl Chem."},{"key":"1301_CR28","volume-title":"Nitric Oxide Biology and Pathobiology","author":"LJ Ignarro","year":"2000","unstructured":"Ignarro LJ. Nitric Oxide Biology and Pathobiology. San Diego: Academic; 2000."},{"key":"1301_CR29","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/S1567-5769(01)00090-X","volume":"1","author":"LR Brunet","year":"2001","unstructured":"Brunet LR. Nitric oxide in parasitic infections. Int Immunopharmacol. 2001;1:1457\u201367.","journal-title":"Int Immunopharmacol"},{"key":"1301_CR30","first-page":"131","volume":"9","author":"M Colasanti","year":"2002","unstructured":"Colasanti M, Gradoni L, Mattu M, Persichini T, Salvati L, Venturini G, et al. Molecular basis for the anti-parasitic effect on NO. Int J Mol Med. 2002;9:131\u20134.","journal-title":"Int J Mol Med."},{"key":"1301_CR31","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.pt.2006.02.014","volume":"22","author":"A Rivero","year":"2006","unstructured":"Rivero A. Nitric oxide: an antiparasitic molecule of invertebrates. Trends Parasitol. 2006;22:219\u201325.","journal-title":"Trends Parasitol."},{"key":"1301_CR32","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ijpddr.2012.05.001","volume":"2","author":"RS Treger","year":"2012","unstructured":"Treger RS, Cook AG, Rai G, Maloney DJ, Simeonov A, Jadhav A, et al. Oxadiazole 2-oxides are toxic to the human hookworm, Ancylostoma ceylanicum, however glutathione reductase is not the primary target. Int J Parasitol Drugs Drug Resist. 2012;2:171\u20137.","journal-title":"Int J Parasitol Drugs Drug Resist."},{"key":"1301_CR33","doi-asserted-by":"crossref","first-page":"4412","DOI":"10.1021\/jm00051a020","volume":"37","author":"C Medana","year":"1994","unstructured":"Medana C, Ermondi G, Fruttero R, Di Stilo A, Ferretti C, Gasco A. Furoxans as nitric oxide donors. 4-phenyl-3-furoxancarbonitrile: thiol-mediated nitric oxide release and biological evaluation. J Med Chem. 1994;37:4412\u20136.","journal-title":"J Med Chem"},{"key":"1301_CR34","doi-asserted-by":"crossref","first-page":"5003","DOI":"10.1021\/jm0704595","volume":"50","author":"MF Buonsanti","year":"2007","unstructured":"Buonsanti MF, Bertinaria M, Di Stilo A, Cena C, Fruttero R, Gasco A. Nitric oxide donor \u03b22-agonists: furoxan derivatives containing the fenoterol moiety and related furazans. J Med Chem. 2007;50:5003\u201311.","journal-title":"J Med Chem."},{"key":"1301_CR35","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/sj.bjp.0706743","volume":"148","author":"CM Turnbull","year":"2006","unstructured":"Turnbull CM, Cena C, Fruttero R, Gasco A, Rossi AG, Megson IL. Mechanism of action of novel NO-releasing furoxan derivatives of aspirin in human platelets. British J Pharm. 2006;148:517\u201326.","journal-title":"British J Pharm."},{"key":"1301_CR36","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1002\/cbic.200300617","volume":"4","author":"G Sorba","year":"2003","unstructured":"Sorba G, Galli U, Cena C, Fruttero R, Gasco A, Morini G, et al. A new furoxan NO-donor rabeprazole derivative and related compounds. ChemBioChem. 2003;4:899\u2013903.","journal-title":"ChemBioChem."}],"container-title":["Parasites & Vectors"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-016-1301-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T10:09:02Z","timestamp":1589623742000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.parasitesandvectors.com\/content\/9\/1\/26"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,20]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["1301"],"URL":"https:\/\/doi.org\/10.1186\/s13071-016-1301-3","relation":{},"ISSN":["1756-3305"],"issn-type":[{"value":"1756-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,20]]},"article-number":"26"}}